Methods of identifying human subjects for treatment of obesity or an obesity-related condition with ciliary neurotrophic factor (CNTF) or a CNTF-related molecule, such as Axokine.RTM., based on the presence of human leukocyte antigen (HLA) DR.beta.1 allele 1501 or the absence of HLA DR.beta.1 allele 0701.